Literature DB >> 8003509

Characterization of an ATP-stimulatable Ca(2+)-independent phospholipase A2 from clonal insulin-secreting HIT cells and rat pancreatic islets: a possible molecular component of the beta-cell fuel sensor.

S Ramanadham1, M J Wolf, P A Jett, R W Gross, J Turk.   

Abstract

Isolated pancreatic islets from rats and humans express a plasmalogen-preferring ATP-stimulatable, Ca(2+)-independent phospholipase A2 (ASCI-PLA2) enzyme which participates in the glucose-stimulated hydrolysis of arachidonate from membrane phospholipids and in insulin secretion. Here we report that clonal insulin-secreting HIT beta-cells contain substantial amounts of endogenous plasmalogens and express a similar ASCI-PLA2 activity with the following properties: (1) Enzymatic activity as well as glucose-induced eicosanoid release and insulin secretion are inhibited by a mechanism-based suicide substrate directed towards ASCI-PLA2. (2) HIT cell ASCI-PLA2 is selectively activated and protected against thermal denaturation by ATP. (3) The magnitude of ASCI-PLA2 activation by the nonhydrolyzable ATP analog AMP-PCP is similar to that by ATP. (4) The ATP concentrations required to activate ASCI-PLA2 fall within physiologic ranges in the presence of Mg2+. (5) ADP induces a concentration-dependent attenuation of the activation of ASCI-PLA2 by ATP. HIT cell ASCI-PLA2 exhibited an apparent isoelectric point of 7.5 on chromatofocusing analysis and was quantitatively adsorbed to an ATP-agarose matrix and selectively desorbed from this column by ATP. Mono-Q anion-exchange analysis of the active ATP-agarose eluant yielded a peak of ASCI-PLA2 activity associated with a single protein band with an apparent molecular mass of 40 kDa. Similar chromatographic behavior of the rat pancreatic islet ASCI-PLA2 activity was observed during sequential ATP-agarose and Mono-Q anion-exchange steps. These results indicate that HIT cells express an ASCI-PLA2 similar to the analogous islet enzyme and suggest that expression of this enzyme and of its preferred plasmalogen substrates may be a general property of insulin-secreting beta-cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8003509     DOI: 10.1021/bi00189a052

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  24 in total

Review 1.  Phospholipase A2 and its potential regulation of islet function.

Authors:  E Simonsson; B Ahrén
Journal:  Int J Pancreatol       Date:  2000-02

Review 2.  Islet complex lipids: involvement in the actions of group VIA calcium-independent phospholipase A(2) in beta-cells.

Authors:  Sasanka Ramanadham; Haowei Song; Shunzhong Bao; Fong-Fu Hsu; Sheng Zhang; Zhongmin Ma; Chun Jin; John Turk
Journal:  Diabetes       Date:  2004-02       Impact factor: 9.461

Review 3.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

4.  Insulin secretory responses and phospholipid composition of pancreatic islets from mice that do not express Group VIA phospholipase A2 and effects of metabolic stress on glucose homeostasis.

Authors:  Shunzhong Bao; Haowei Song; Mary Wohltmann; Sasanka Ramanadham; Wu Jin; Alan Bohrer; John Turk
Journal:  J Biol Chem       Date:  2006-05-27       Impact factor: 5.157

5.  Analyses of Calcium-Independent Phospholipase A2beta (iPLA2β) in Biological Systems.

Authors:  S E Barbour; S Ramanadham
Journal:  Methods Enzymol       Date:  2016-10-18       Impact factor: 1.600

6.  Modulation of the pancreatic islet beta-cell-delayed rectifier potassium channel Kv2.1 by the polyunsaturated fatty acid arachidonate.

Authors:  David A Jacobson; Christopher R Weber; Shunzhong Bao; John Turk; Louis H Philipson
Journal:  J Biol Chem       Date:  2006-12-29       Impact factor: 5.157

7.  Human pancreatic islets express mRNA species encoding two distinct catalytically active isoforms of group VI phospholipase A2 (iPLA2) that arise from an exon-skipping mechanism of alternative splicing of the transcript from the iPLA2 gene on chromosome 22q13.1.

Authors:  Z Ma; X Wang; W Nowatzke; S Ramanadham; J Turk
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

8.  Effects of stable suppression of Group VIA phospholipase A2 expression on phospholipid content and composition, insulin secretion, and proliferation of INS-1 insulinoma cells.

Authors:  Shunzhong Bao; Alan Bohrer; Sasanka Ramanadham; Wu Jin; Sheng Zhang; John Turk
Journal:  J Biol Chem       Date:  2005-11-14       Impact factor: 5.157

9.  Group VIA Phospholipase A2 (iPLA2β) Modulates Bcl-x 5'-Splice Site Selection and Suppresses Anti-apoptotic Bcl-x(L) in β-Cells.

Authors:  Suzanne E Barbour; Phuong T Nguyen; Margaret Park; Bhargavi Emani; Xiaoyong Lei; Mamatha Kambalapalli; Jacqueline C Shultz; Dayanjan Wijesinghe; Charles E Chalfant; Sasanka Ramanadham
Journal:  J Biol Chem       Date:  2015-03-11       Impact factor: 5.157

10.  Inhibition of Ca2+-independent phospholipase A2 results in insufficient insulin secretion and impaired glucose tolerance.

Authors:  Keying Song; Xu Zhang; Chunying Zhao; Natasha T Ang; Zhongmin Alex Ma
Journal:  Mol Endocrinol       Date:  2004-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.